Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijid.2020.07.072 http://scihub22266oqcxt.onion/10.1016/j.ijid.2020.07.072 32763444!7403134!32763444     free     free     free       Int+J+Infect+Dis 2020 ; 99 (ä): 276-278 Nephropedia Template TP {{tp|p=32763444|t=2020. Critical illness myopathy after COVID-19 |pdf=|usr=}}{{32763444}} gab.com Text Critical illness myopathy after COVID-19 JO: Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32763444 #FOAvip This paper describes a patient who developed diffuse and symmetrical muscle weakness after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). The patient underwent a neurophysiological protocol, including nerve conduction studies, concentric needle electromyography (EMG) of the proximal and distal muscles, and direct muscle stimulation (DMS). Nerve conduction studies showed normal sensory conduction and low-amplitude compound muscle action potentials (CMAPs). EMG revealed signs of myopathy, which were more pronounced in the lower limbs. The post-DMS CMAP was absent in the quadriceps and of reduced amplitude in the tibialis anterior muscle. Based on these clinical and neurophysiological findings, a diagnosis of critical illness myopathy was made according to the current diagnostic criteria. Given the large number of patients with COVID-19 who require long ICU stays, many are very likely to develop ICU-acquired weakness, as did the patient described here. Health systems must plan to provide adequate access to rehabilitative facilities for both pulmonary and motor rehabilitative treatment after COVID-19. Twit Text FOAVip Critical illness myopathy after COVID-19 ????Int J Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=32763444 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32763444 #FOAvip English Wikipedia <ref>{{Cite pmid|32763444}}</ref> Critical illness myopathy after COVID-19 #MMPMID32763444 Bagnato S; Boccagni C; Marino G; Prestandrea C; D'Agostino T; Rubino F Int J Infect Dis 2020[Oct]; 99 (ä): 276-278 PMID32763444show ga This paper describes a patient who developed diffuse and symmetrical muscle weakness after a long stay in the intensive care unit (ICU) due to coronavirus disease 2019 (COVID-19). The patient underwent a neurophysiological protocol, including nerve conduction studies, concentric needle electromyography (EMG) of the proximal and distal muscles, and direct muscle stimulation (DMS). Nerve conduction studies showed normal sensory conduction and low-amplitude compound muscle action potentials (CMAPs). EMG revealed signs of myopathy, which were more pronounced in the lower limbs. The post-DMS CMAP was absent in the quadriceps and of reduced amplitude in the tibialis anterior muscle. Based on these clinical and neurophysiological findings, a diagnosis of critical illness myopathy was made according to the current diagnostic criteria. Given the large number of patients with COVID-19 who require long ICU stays, many are very likely to develop ICU-acquired weakness, as did the patient described here. Health systems must plan to provide adequate access to rehabilitative facilities for both pulmonary and motor rehabilitative treatment after COVID-19. |*Betacoronavirus[MESH] |*Critical Illness[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Female[MESH] |Humans[MESH] |Middle Aged[MESH] |Muscular Diseases/*etiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications[MESH]Critical illness myopathy after COVID-19 (epmc).pdf DeepDyve Pubget Overpricing